Fulcrum Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Fulcrum Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2020 to Q2 2024.
  • Fulcrum Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -7.61 %, a 78.8% increase year-over-year.
  • Fulcrum Therapeutics, Inc. annual Return On Assets for 2023 was -33.6 %, a 31.9% increase from 2022.
  • Fulcrum Therapeutics, Inc. annual Return On Assets for 2022 was -49.4 %, a 19.9% decline from 2021.
  • Fulcrum Therapeutics, Inc. annual Return On Assets for 2021 was -41.2 %, a 25.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -7.61 +28.3 +78.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -37.2 +6.7 +15.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -33.6 +15.8 +31.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -35 +12.7 +26.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -35.9 +10.1 +21.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -43.9 -1.58 -3.73% Jan 1, 2023 Mar 31, 2023
Q4 2022 -49.4 -8.18 -19.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -47.7 -3.54 -8.01% Jul 1, 2022 Sep 30, 2022
Q2 2022 -46 +5.81 +11.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -42.3 +6.1 +12.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -41.2 +14.2 +25.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -44.2 +12 +21.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -51.8 +5.52 +9.63% Apr 1, 2021 Jun 30, 2021
Q1 2021 -48.4 +18.1 +27.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -55.4 Oct 1, 2020 Dec 31, 2020
Q3 2020 -56.2 Jul 1, 2020 Sep 30, 2020
Q2 2020 -57.3 Apr 1, 2020 Jun 30, 2020
Q1 2020 -66.6 Jan 1, 2020 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.